Verification evidence is still being completed.
Lead Biologics
Helsingborg, Sweden
- Verified lead
- Anki Malmborg Hager
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
- Review cycle
- May 2026
- Full address
- Lead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Lead Biologics contact page confirming the Helsingborg address.
- Editorial note
- Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
Official leadership disclosure, Official Helsingborg address disclosure, Biologics platform claim
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Lead Biologics
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech · Development-stage biologics platform
Lead Biologics runs biologics discovery, antibody program development, and therapeutics platform work in Helsingborg, Sweden.
- Lead
- Anki Malmborg Hager (verified ↗)
- Address
- Lead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Development-stage biologics platform
- Capabilities
- Biologics Discovery · Antibody Program Development · Therapeutics Platform Work
- Founded
- 2020
- Headcount
- 1-10
Anki Malmborg Hager
CEO
Official Lead Biologics contact page listing the Helsingborg address and CEO contact.
Open sourceDevelopment-stage biologics platform
Helsingborg, Sweden. Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech. Review completed on 22 Mar 2026.
Swedish corporate and therapeutics-development oversight
Official leadership disclosure, Official Helsingborg address disclosure, Biologics platform claim
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Lead Biologics located?
- Lead Biologics operates from Lead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden, Helsingborg, Sweden.
- Who runs Lead Biologics?
- Lead Biologics is led by Anki Malmborg Hager, CEO. Verified 22 Mar 2026.
- What does Lead Biologics do?
- Lead Biologics runs biologics discovery, antibody program development, and therapeutics platform work in Helsingborg, Sweden. Core capabilities: Biologics Discovery, Antibody Program Development, Therapeutics Platform Work.
Related technical briefs
Briefs that name Helsingborg as a covered market or city.
